Marketscreener
Published November 16, 2026
Helus Pharma's psychedelic depression drug succeeds in late-stage study | MarketScreener
Read the full story at Marketscreener
Nov 16 - Helus Pharma said on Monday its experimental psychedelic drug met the main goal of a late-stage trial in patients with major depressive.
Surfaced by 4 Google Alerts
- Psychedelics
- Magic mushrooms
- Psychedelic biotech
- Ketamine